Elgia Therapeutics, Inc.
San Diego, CA
- UEI
- KNWNN7JMAMT7
- CAGE
- 94W38
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 10686 Hunters Glen Dr, San Diego, CA 92130, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Optimizing brain penetrance of caspase-6 inhibitors to treat neurodegenerative diseases | National Institute on Aging (NIH) | $467,916 |
SBA capabilities narrative
Elgia Therapeutics is a drug discovery company with a novel target platform to deliver first-in-class, small molecule therapies for chronic inflammation, fibrosis and inflammasome diseases.
Quick answers
Is Elgia Therapeutics, Inc. registered in SAM.gov?
Yes. Elgia Therapeutics, Inc.'s SAM.gov registration is active through January 5, 2027.
What is Elgia Therapeutics, Inc.'s most recent federal award?
Elgia Therapeutics, Inc.'s most recent federal grant award is Optimizing brain penetrance of caspase-6 inhibitors to treat neurodegenerative diseases (R41AG078036), from National Institute on Aging (NIH), on September 30, 2023.
On GovTribe
See Elgia Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors